Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.25 - $11.7 $5 - $257
-22 Reduced 0.5%
4,410 $1,000
Q2 2022

Aug 12, 2022

SELL
$0.3 - $1.31 $142,654 - $622,925
-475,516 Reduced 99.08%
4,432 $1,000
Q1 2022

May 16, 2022

SELL
$0.61 - $1.84 $18,723 - $56,476
-30,694 Reduced 6.01%
479,948 $662,000
Q4 2021

Feb 08, 2022

BUY
$1.16 - $2.74 $546,182 - $1.29 Million
470,847 Added 1183.18%
510,642 $618,000
Q3 2021

Nov 15, 2021

SELL
$2.62 - $5.43 $180,824 - $374,762
-69,017 Reduced 63.43%
39,795 $104,000
Q2 2021

Sep 13, 2021

BUY
$5.06 - $8.15 $550,588 - $886,817
108,812 New
108,812 $577,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.